Activities in the field of rare diseases in Slovakia. CISARIK František Faculty Hospital Žilina
|
|
- Neil Ford
- 6 years ago
- Views:
Transcription
1 Activities in the field of rare diseases in Slovakia CISARIK František Faculty Hospital Žilina
2 As we progress? Slovak National Strategy for the Development of Health Care for Patients with Rare Diseases was adopted by Government of the Slovak Republic on 24 October 2012 (Národná stratégia rozvoja zdravotnej starostlivosti o pacientov so zriedkavými chorobami na roky UZNESENIE VLÁDY SLOVENSKEJ REPUBLIKY č. 578 z 24. októbra 2012 )
3 Vision Alliance for RD in Slovakia Commission of the MH of the SR for RD Adoption of criteria for CE European reference network Financial support for RD activities RD registers
4 Vision Alliance for RD in Slovakia Commission of MH of the SR for RD Statute of the Commission of the MH of the Slovak Republic for RD was adopted by the Minister on 24.november 2014 Štatút Komisie Ministdrstva zdravotníctva Slovenskej republiky pre zriedkavé choroby (Rare Diseases RD)
5 Upgraded concept of health care in the field of medical genetics has been adopted by the MH on January 31, 2014 Koncepcia zdravotnej starostlivosti v odbore lekárska genetika, Číslo: S01260-OZS-2014 Dňa: 31. januára 2014
6 Professional guidance document of the Ministry of Health on the standardization of genetic diagnostics of syndrome of hereditary breast and ovarian carcinoma (HBOC) is just before approval
7 National Newborn Screening Centre + 3 regional Recall Centres providing definitive diagnostic procedures and continuous management of confirmed cases Professional guidance of the Ministry of Health of nationwide screening for congenital hypothyroidism, congenital adrenal hyperplasia, cystic fibrosis and certain inherited metabolic disorders in newborns and health care for captured cases November 16, 2012
8 Newborn screening expanded (2012) panel of screened diseases from 4 congenital hypothyroidism, phenylketonuria, congenital adrenal hyperplasia, and cystic fibrosis to 13, to include hyperphenylalaninemia(hpa), leucinosis (MSUD), MCAD, LCHAD, VLCAD, CPT I., CPT II.A, CACT, glutaric aciduria type I (GA I), and isovaleric aciduria (IVA). Od 1. januára 2013 na Slovensku vyšetrujeme v skríningu dedičných metabolických porúch metódou tandemovej hmotnostnej spektrometrie LC- MS/MS nasledovné ochorenia: FKU/HPA, MSUD leucinózu, MCAD deficit acyl CoA dehydrogenázy MK so stredným reťazcom, VLCAD - deficit acyl CoA dehydrogenázy MK s veľmi dlhým reťazcom, LCHAD - deficit 3OH acyl CoA dehydrogenázy MK s dlhým reťazcom, CPT I. deficit karnitínpalmitoyltransferázy I., CPT II/CACT - deficit karnitínpalmitoyltransferázy II/deficit karnitín acylkarnitíntranslokázy, GA.I. glutarová acidúria I, IVA izovalerová acidúria.
9 Basic pillars of the national plan European reference network Research Centres of expertise Quality control Therapy Registries of RD
10 National Registry of Congenital Anomalies Why we decided to use National Registry of Congenital Anomalies as platform for development of Registry of Rare Diseases in Slovakia? Why with substantial cooperation with clinical geneticists now? 1. This Registry of Congenital Anomalies has had a long and successful history in Slovakia. The data have been published since Over these years, the registry has undergone more changes in the system of reporting as significant changes in discovering aetiological connection with congenital anomalies took place.
11 Why we decided to use National Registry of Congenital Anomalies as platform for development of Registry of Rare Diseases in Slovakia? Why with substantial cooperation with clinical geneticists now? 2. As 85% of rare diseases are genetic and a lot of congenital anomalies are genetically conditioned, we were looking for the possibilities of using the existing registries run by the National Health Information Centre to create a virtual registry of rare diseases. In fact, the existing National Registry of Congenital Anomalies appears to be the closest in its nature. 3. On the other hand, provision of medical genetics services in the Slovak Republic has now well established organisational structure, network of providers, personnel and methodical conditions, which ensure high-level services.
12 Year 2013 : Number of CH.A. according to type of risk PRENATALLY DETECTED CHROMOSOMAL ANOMALY RISK of CH.A/ No of cases DS T18 T13 GA Other All Age over 35 years/ screening negative- (745) Positive screening (1968) Ultrasonography (338) Genetic clasical (113) Other risk (74) Alltogether (3252) DS=Down sy., T18=trisomy 18, T13=trisomy 13, GA= gonosomal anamaly, Other= other chromosomal anomalies Genetic register SR Registry of prenatally diagnosed genetic diseases Clinical geneticists have experience with so-called Genetic registry SR, which was run under Slovak Society of Medical Genetics for more than 10 years. Another long term registry run under Slovak Society of Medical Genetics is Registry of Prenatal Genetic Diagnosis (prenatally diagnosed genetic disorders), which we organize for 20 years.
13 Pilot steps in creation Registry of Rare diseases According to Act No. 153/2013 on the National Health Information System and on Amendments and Additions to Certain Laws, since 2014, The National Registry of Patients with Congenital Anomalies consists of: Registry of Congenital Anomalies (all congenital anomalies including inherited and genetic disorders and rare diseases). Registry of Congenital Heart Defects (specific reporting). New reporting forms: Report on Congenital Anomalies in Live Births and Stillbirths (filed in by neonatologists and pedatricians, till now without ORPHA codes) Report on Congenital Anomalies Inherited Diseases, Genetic Disorders and Rare Diseases (new report filed in by clinical geneticists, using ICD 10, OMIM and ORPHA codes ) Report on Congenital Anomalies of the Foetus Genetics (new report filed in by clinical geneticists,using ICD 10, OMIM and ORPHA codes )
14 LIST OF NATIONAL HEALTH REGISTRIES National Registry of Electronic Health Records National Cancer Registry National Diabetes Mellitus Registry National Congenital Disease Registry National Cardiovascular Registry National Registry of Neurological Disorders National Registry of Chronic Pulmonary Disease National Tuberculosis Registry National Arthroplasty Registry National Registry of Patients with Inflammatory Rheumatic Disease National Registry of Persons with Injury Requiring Inpatient Healthcare National Registry of Persons Suspected of Being Neglected, Abused and on Victims of Violence
15 Ďakujem za pozornosť
State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report
State of the Art of Rare Disease Activities in EU Member States and Other European Countries Slovak Republic Report Definition of a Rare Disease The Slovak Republic has adopted the European Commission
More informationOverview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy
Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Alan R. Fleischman, M.D. Senior Vice President and Medical Director Chair, Federal Advisory Committee,
More informationState of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Belgium Report
State of the Art of Rare Disease - Activities in EU Member States and Other European Countries Definition of a Rare Disease Belgium Report The definition of rare diseases in the Belgian Plan for Rare Diseases
More informationNewborn Screening: Focus on Treatment
Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public
More information[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995
RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE
More informationTitle: Assessing Recommendations Related To Timeliness of Newborn Screening
Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)
More informationPositive Newborn Screens: What do you do next?
Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric
More informationNewborn Bloodspot Screening Information for parents
Newborn Bloodspot Screening Information for parents You will be offered a bloodspot screening test for your newborn baby for several rare but serious conditions. The sample for this test is usually taken
More informationNewborn Bloodspot Screening Information for parents
Newborn Bloodspot Screening Information for parents You will be offered a bloodspot screening test for your newborn baby for several rare but serious conditions. The sample for this test is usually taken
More information(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;
Ga. Comp. R. & Regs. r. 511-5-5-.02 Definitions Rule 511-5-5-.02. Definitions (a) "Abnormal test result" is a test result from blood testing or physiologic monitoring that is outside the screening limits
More informationState of the Art of Rare Disease Activities in EU Member States and Other European Countries Croatia Report
State of the Art of Rare Disease Activities in EU Member States and Other European Countries Croatia Report Definition of a Rare Disease Croatia has adopted the European Commission definition of a rare
More informationFor the Ongoing Management of Babies under 1 year old.
Pathway Author: Nicy Turney, Senior Nurse Professional Lead, Health Visiting 19.06.17 For the Ongoing Management of Babies under 1 year old. Check Health Records (CHR) to undertake daily checks to identify:
More informationSlide 1: Newborn Bloodspot Screening for Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
Slide 1: Newborn Bloodspot Screening for Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD) The information has been produced with thanks to the NHS Newborn Blood Spot Screening Programme. 1 Slide
More informationTIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN
TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN Susan Tanksley, PhD May 19, 2015 TIMELINESS - BACKGROUND In order to effectively
More informationState of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Portugal Report
State of the Art of Rare Disease - Activities in EU Member States and Other European Countries Definition of a Rare Disease Portugal Report Portugal has adopted the European Commission definition of a
More informationNewborn Genetic Testing & Surveillance System
Georgia Newborn Genetic Testing & Surveillance System State GA Statute/ Rule STATUTE: Chapter 1 Chapter 2 Chapter 12 Title 33 Chapter 54 RULE: 290-5-.02 and 290-5- 24 Language Specific to Genetic Testing
More informationNEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Answers for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More informationFurther expansion of the neonatal screening panel in the Netherlands
Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1
More informationHealth Chapter ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE
ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE CHAPTER 420-10-1 CARE AND TREATMENT OF INFANTS IDENTIFIED THROUGH THE NEWBORN SCREENING
More informationFor Your Baby s Health Department of Health
Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your
More informationThe Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot
The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State Caroline T. Nucup-Villaruz, MD Primary Author NBS Consultant - Disorder FU Santosh Shaunak Co-Author & Presenter Laboratory
More informationRoutine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015
Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is
More informationCentres of reference for rare diseases expectations based on Polish experience. Małgorzata Krajewska-Walasek
Centres of reference for rare diseases expectations based on Polish experience Małgorzata Krajewska-Walasek Department of Medical Genetics, The Children s Memorial Health Institute, Warsaw, Poland My presentation
More informationBULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)
BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National
More informationCommunity Genetics. Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital
Community Genetics Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital Training Course in Sexual and Reproductive Health Research Geneva 2011 Definition of Community Genetics
More informationNewborn Screening in Manitoba. Information for Health Care Providers
Newborn Screening in Manitoba Information for Health Care Providers Newborn screening: a healthy start leads to a healthier life Health care professionals have provided newborn screening for phenylketonuria
More informationNewborn Metabolic Screening Programme Annual Report
Newborn Metabolic Screening Programme Annual Report January to December 2015 Disclaimer This publication reports on information provided to the Ministry of Health by the Auckland District Health Board.
More informationNewborn Screening & Methods for Diagnosing Inborn Errors of Metabolism
Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism Patricia Jones, PhD DABCC FACB UT Southwestern Medical Center Children s Medical Center Dallas, Texas Learning Objectives Justify
More informationHealth and Wellness for all Arizonans. azdhs.gov
To identify newborns with certain, rare disorders and assist families of affected infants so that they receive appropriate and timely treatment to prevent or delay serious medical problems. To identify
More informationNewborn Metabolic Screening Programme. Annual Report
Newborn Metabolic Screening Programme Annual Report January to December 2016 1 Disclaimer This publication reports on information provided to the Ministry of Health by the Auckland District Health Board.
More informationUK Newborn Screening for X-ALD - progress from a lab perspective
UK Newborn Screening for X-ALD - progress from a lab perspective Mrs. Leila Cornes Senior Clinical Scientist, Newborn Screening Southmead Hospital, Bristol May 2016 C26:0-lysoPC C26:0-lysophosphatidylcholine
More informationNewborn Screening: Blood Spot Disorders
Newborn Screening: Blood Spot Disorders Arizona s Newborn Screening Program Program Overview Panel of Disorders Disorder Descriptions Program Components Hospitals ADHS Lab ADHS Follow-up ADHS Billing Medical
More informationInborn Errors of Metabolism From Neonatal Screening to Metabolic Pathways
19 May 2015 Hospital Authority Convention 2015 Corporate Scholarship Presentation II Paediatric Services Inborn Errors of Metabolism From Neonatal Screening to Metabolic Pathways Dr Grace Poon Associate
More informationAnnual Report Calendar Year 2015
Annual Report Calendar Year 2015 Page 1 of 19 Contents 1. SAMPLE VOLUMES IN 2015...3 1.1 SCREENING SAMPLES...3 1.1.1 INFANTS SCREENED...3 1.1.2 DECLINED/DEFERRED TESTING...4 1.1.3 MISSED SCREENS...5 1.2
More informationAtlas of Genetics and Cytogenetics in Oncology and Haematology
Atlas of Genetics and Cytogenetics in Oncology and Haematology Neonatal Screening I - INTRODUCTION 1- Neonatal screening for a metabolic disease must address a frequent pathology for which there is an
More informationHow MS/MS Revolutionized Newborn Screening
How MS/MS Revolutionized Newborn Screening David S Millington, PhD Medical Research Professor of Pediatrics Director, Biochemical Genetics Laboratory Duke University Medical Center NEWBORN SCREENING IN
More informationA Guide for Prenatal Educators
A Guide for Prenatal Educators Why Teach Newborn Screening This booklet is designed to make it easy for you, a prenatal educator, to effectively inform expectant parents about newborn screening. All of
More informationNewborn Metabolic Screening Programme
Newborn Metabolic Screening Programme Annual Report January to December 2017 Released 2018 health.govt.nz Disclaimer This publication reports on information provided to the Ministry of Health by the Auckland
More informationComprehensive cost-utility analysis of newborn screening strategies Carroll A E, Downs S M
Comprehensive cost-utility analysis of newborn screening strategies Carroll A E, Downs S M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS
More informationInformation for health professionals
Introduction of a new screening test for newborn babies in Wales Newborn bloodspot screening for Medium chain acyl-coa dehydrogenase deficiency (MCADD) Newborn bloodspot screening for MCADD is being introduced
More informationPost mortem investigation of Inherited Metabolic Disease - the last opportunity for a diagnosis -
Post mortem investigation of Inherited Metabolic Disease - the last opportunity for a diagnosis - Dr Simon Olpin Lead Clinical Scientist in Inherited Metabolic Disease Sheffield Children s Hospital SIDS/SUDI
More informationDIAGNOSIS OF FATTY ACID OXIDATION DISORDERS BY MASS SPECTROMETRY
DIAGNOSIS OF FATTY ACID OXIDATION DISORDERS BY MASS SPECTROMETRY Eric Law Chemical Pathology, PWH 15 January 2010 Outline of talk Basic of mitochondrial fatty acid oxidation (FAO) Laboratory investigations
More informationNewborn Screening: What s New?
Newborn Screening: What s New? Patricia M. Jones, PhD (Department of Pathology, University of Texas Southwestern Medical Center and Children s Medical Center of Dallas, Dallas, TX) DOI: 10.1309/LMOOXWVPSM5FC3B6
More informationMost common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine
More informationNEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Information for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More informationNewborn Screening in Japan: Restructuring for the New Era
Plenary 13 Newborn Screening in Japan: Restructuring for the New Era Seiji Yamaguchi, 1 MD Abstract Nationwide neonatal mass screening for inherited metabolic diseases has started in Japan since 1977.
More informationMISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING Protecting your newborn MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES [ 1 ] NEWBORN SCREENING [ 2 ] FREQUENTLY ASKED QUESTIONS [ 4 ] DISORDERS INCLUDED IN NEWBORN SCREENING [ 12 ]
More informationInformation for health professionals
Changes to the Newborn Bloodspot Screening Policy for Congenital Hypothyroidism (CHT) in Preterm Babies A UK policy change has been agreed that will mean changes to: which preterm babies require second
More informationAlvaro Serrano Russi MD University of Iowa Hospitals and Clinics
Retrospective Analysis of the Region 4 Post Analytical Tool and Confirmatory Testing for Long Chain Fatty Acid Oxidation Disorders Screened in the State of Iowa Alvaro Serrano Russi MD University of Iowa
More informationAssessing Mothers Knowledge of the Wisconsin Newborn Screening Program. Sara Wolfgram UW Master of Public Health Symposium August 11, 2006
Assessing Mothers Knowledge of the Wisconsin Newborn Screening Program Sara Wolfgram UW Master of Public Health Symposium August 11, 2006 Background Wisconsin Newborn Screening (NBS): Began in 1965 Heel
More informationNEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES Table of Contents NEWBORN SCREENING...1 FREQUENTLY ASKED QUESTIONS...2 DISORDERS INCLUDED IN NEWBORN SCREENING...4
More informationNEWBORN METABOLIC SCREEN, MINNESOTA
Lab Dept: Test Name: Chemistry NEWBORN METABOLIC SCREEN, MINNESOTA General Information Lab Order Codes: Synonyms: CPT Codes: Test Includes: PKUN Newborn Screen for Hyopothyroidism, Phenylketonuria (PKU),
More informationAnnual Report Calendar Year 2014
Annual Report Calendar Year 2014 1 Contents 1. SAMPLE VOLUMES IN 2014...4 1.1 SCREENING SAMPLES...4 1.1.1 INFANTS SCREENED...4 1.1.2 DECLINED/DEFERRED TESTING...5 1.1.3 MISSED SCREENS...6 1.2 NON-SCREENING
More informationNewborn screening for additional metabolic diseases using second-tier strategies Juergen G. Okun, PhD
Newborn screening for additional metabolic diseases using second-tier strategies Juergen G. Okun, PhD 5th EFLM-UEMS European Joint Congress in Laboratory Medicine 10-13 October 2018 in Antalya, Turkey
More informationSLOVAK BEER AND MALT ASSOCIATION RESPONSIBILITY DAY
SLOVAK BEER AND MALT ASSOCIATION RESPONSIBILITY DAY Report from the Health and Education Campaign Brussels, 23 November 2012 Campaign Information Aim of Responsibility Day : to prevent excessive alcohol
More informationBlue represents coding updates. G0389 with diagnosis V81.2, V15.82, or with diagnosis V79.1, or
An Independent Licensee of the Blue Cross and Blue Shield Association Preventive Care Services The following is a list of preventive services (HCP rider) along with the diagnoses and procedure codes that
More informationNational. Screening Report. Germany 2016
National Screening Report Germany 2016 German Society for Neonatal Screening (DGNS) Uta Nennstiel, Anja Lüders, Oliver Blankenstein, Uta Ceglarek, Regina Ensenauer, Gwendolyn Gramer, Nils Janzen, Jeannette
More informationNational. Screening Report. Germany 2014
National Screening Report Germany 2014 German Society for Neonatal Screening (DGNS) Uta Nennstiel-Ratzel, Anja Lüders, Oliver Blankenstein, Uta Ceglarek, Regina Ensenauer, Gwendolyn Gramer, Jeannette Klein,
More informationSlide 1: The information has been produced with thanks to the NHS Newborn Blood Spot Screening Programme.
Slide 1: The information has been produced with thanks to the NHS Newborn Blood Spot Screening Programme. 1 Slide 2: Aim 2 Slide 3: Objectives 3 Slide 4: What is the aim of newborn bloodspot screening?
More informationThe EU rare diseases policy framework: the context for ERNs
The EU rare diseases policy framework: the context for ERNs Jaroslaw Waligora DG Health and Food Safety, European Commission Unit C.1, Programme Management and Diseases Report from an expert group of the
More informationNational. Screening Report Deutsche Gesellschaft für Neugeborenenscreening DGNS
National Report 2007 Deutsche Gesellschaft für Neugeborenenscreening DGNS Dr. med. Uta Nennstiel-Ratzel MPH, Dr. med. Anja Lüders MPH, Dr. med. Oliver Blankenstein, Dr. rer. nat. Uta Ceglarek, Dr. med.
More informationNEWBORN SCREENING IN JAPAN
NEWBORN SCREENING IN JAPAN Kikurnaro Aoki KagawaNutrition University, Saitama, Japan Abstract. In the 19701s, the government began to take steps for the treatment of congenital diseases. Mass newborn screening
More informationERNDIM QA Scheme for qualitative blood spot acylcarnitine analysis. Annual Report 2010
UniversitätsKlinikum Heidelberg Universitätsklinik für Kinder- und Jugendmedizin Stoffwechselzentrum Heidelberg Stoffwechsellabor Im Neuenheimer Feld 430 69120 Heidelberg To Stoffwechselzentrum Heidelberg
More informationHONG KONG COLLEGE OF PAEDIATRICIANS. Proposal of the service model & training programme of Metabolic Medicine
HONG KONG COLLEGE OF PAEDIATRICIANS Committee for Subspecialty Boards Forum on the Impact of Hong Kong Children s Hospital on the future paediatric training and service Proposal of the service model &
More informationState of the Art of Rare Disease Activities in EU Member States and Other European Countries. Hungary Report
State of the Art of Rare Disease Activities in EU Member States and Other European Countries Definition of a Rare Disease Hungary Report Hungary has adopted the European Commission definition of a rare
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationSelective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain.
Selective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain. Jamal Golbahar PhD Associate Professor of Molecular Medicine, Department of Molecular Medicine,
More informationFatty Acid Oxidation Disorders Organic Acid Disorders
Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial,
More informationAnnual Report to the Newborn Screening Ontario Advisory Council Calendar Year 2017
Annual Report to the Newborn Screening Ontario Advisory Council Calendar Year 2017 415 Smyth Road, Ottawa Ontario K1H 8M8 Phone: 6137383222 1877NBS8330 Fax: 6137380853 Contents 1. SAMPLE VOLUMES IN 2017...4
More informationNewborn Bloodspot Screening (NBS) Training for Health Visitors. December 2017
Newborn Bloodspot Screening (NBS) Training for Health Visitors www.newbornbloodspotscreening.wales.nhs.uk December 2017 Aims To enable you to gain a clear understanding of the following: Aim and rationale
More informationHistory of Metabolic Tests. Dr Mick Henderson Biochemical Genetics Leeds and Manchester
History of Metabolic Tests Dr Mick Henderson Biochemical Genetics Leeds and Manchester This presentation Wont just be a history lesson But there will be some of that! Hopefully will give an impression
More informationSubject: Preventive Services Policy Effective Date: 08/2017 Revision Date: 05/2018
Subject: Preventive s Policy Effective Date: 08/2017 Revision Date: 05/2018 DESCRIPTION The Affordable Care Act (ACA) requires nongrandfathered health plans to cover evidence-based preventive care and
More informationAttachment 1. Newborn Screening Program Description
Attachment 1 Newborn Screening Program Description The core mission of Texas Newborn Screening Program is to save children s lives through the early detection of life-threatening disorders. 34 Newborn
More informationDisclosures. Update on Medical Genetics for Family Practitioners. Objectives. Genetic Testing. Types of Genetic Tests. Dogma of Genetics 08/05/2018
Update on Medical Genetics for Family Practitioners Genetic Testing, Newborn Screening, and Direct to Consumer Testing Sandhya Parkash, MD, FRCPC, FCCMG Maritime Medical Genetics Service, IWK Health Centre
More informationGenetic counselling in PGD
Genetic counselling in PGD Sérgio Castedo Serviço de Genética Faculdade de Medicina do Porto scastedo@netcabo.pt Disclosure of interests Sérgio Castedo is the CEO of GDPN, a private genetics diagnostic
More information2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE
2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN CYPRUS This work was financed by the EUCERD Joint Action: Working for Rare Diseases
More informationNewborn Screening in Washington State Saving lives with a simple blood spot
Newborn Screening in Washington State Saving lives with a simple blood spot Ashleigh Ragsdale, MPH Gauri Gupta, MScPH Objectives Newborn Screening Overview Process and Law Completing Collection Cards Video
More informationFlow of samples and information for newborn screening in a model of publicprivate
Flow of samples and information for newborn screening in a model of publicprivate partnership Marzia Pasquali, PhD, FACMG Associate Professor of Pathology, University of Utah Medical Director, Biochemical
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
MEDICAL FOODS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are
More informationPreventive Care Services Summary
Preventive Care Services Summary Below is a list of preventive services along with the diagnoses and procedure codes that Community Health Options has determined to meet or exceed the requirements and
More informationNational. Screening Report 2008 DGNS
National Report 2008 DGNS Deutsche Gesellschaft für Neugeborenenscreening e.v. Dr. med. Uta Nennstiel-Ratzel MPH, Dr. med. Anja Lüders MPH, Dr. med. Oliver Blankenstein, Dr. rer. nat. Uta Ceglarek, Dr.
More informationSUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure
SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure Subject: NEWBORN SCREENING FOR METABOLIC DEFICIENCIES Prepared By: Yolaine Henry Edit
More informationWhat is the Experience of Family Physicians Regarding Patient s Clinical Genetic Questions?
What is the Experience of Family Physicians Regarding Patient s Clinical Genetic Questions? Rick Kellerman, MD, John Dorsch, MD, Doug Woolley, MD, MPH, Terry Ast, BA Department of Family and Community
More informationInborn Errors of Metabolism Clinical Approach to Diagnosis and Treatment
Case Scenario: 15 year old girl presented in ED with aggressive behaviour and hallucinations. No associated fever, vomiting, seizures or developmental concerns Previously well Inborn Errors of Metabolism
More informationUK National Screening Committee Screening for Congenital Adrenal Hyperplasia in Children 19 November 2015
UK National Screening Committee Screening for Congenital Adrenal Hyperplasia in Children 19 November 2015 Aim 1. To ask the UK National Screening Committee to make a recommendation, based upon the evidence
More informationCOUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC)
L 327/34 COUNCIL RECOMMDATION of 2 December 2003 on cancer screening (2003/878/EC) THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular
More informationNEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY
GMJ GULF MEDICAL JOURNAL ORAL PROCEEDINGS NEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY I.A. Shaafie 1 *, A.D. Vijay Raju 2, P.K. Menon 3 1Division
More informationFatty Acid Oxidation Disorders- an update. Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London
Fatty Acid Oxidation Disorders- an update Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London An update. Overview of metabolism Clinical presentation and outcome Diagnostic
More informationJoshua Hellmann Foundation Newborn Metabolic Screening Program Clinical Protocol
Joshua Hellmann Foundation Newborn Metabolic Screening Program Clinical Protocol Centre of Inborn Errors of Metabolism The Chinese University of Hong Kong Version 7 Effective Date: 15 th February 2016
More informationMetabolomic Analysis for Newborn Screening and Diagnosis of Metabolic Disorders
Metabolomic Analysis for Newborn Screening and Diagnosis of Metabolic Disorders Mass Spectrometry and Separation Sciences for Laboratory Medicine Chicago October 1-2, 2015 Michael J. Bennett PhD, FRCPath,
More informationServices. Colorado RegionEALTH CARE REFORM UPDATE
Health Care Reform Preventive Hpreventive Services Services Colorado Region Colorado RegionEALTH CARE REFORM UPDATE Your guide to preventive services for the Preventive services coverage for over 65 years,
More informationMINISTRY OF HEALTH OF THE REPUBLIC OF CROATIA NATIONAL PROGRAMME FOR RARE DISEASES
MINISTRY OF HEALTH OF THE REPUBLIC OF CROATIA NATIONAL PROGRAMME FOR RARE DISEASES 2015 2020 Zagreb, February 2015 Contents NATIONAL PROGRAMME... 1 FOR RARE DISEASES 2015 2020... 1 CONTENTS... 2 1. INTRODUCTION...4
More informationMedium-chain acyl-coa dehydrogenase (MCAD) deficiency and Expanded Newborn Screening in Japan
Medium-chain acyl-coa dehydrogenase (MCAD) deficiency and Expanded Newborn Screening in Japan Seiji YAMAGUCHI, MD Department of Pediatrics, Shimane University (co-authors) Jamiyan Purevsuren, Yuki Hasegawa,
More informationMeeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission
Meeting with EMA: cooperation in the field of ERNs Enrique Terol DG SANTE European Commission London 16 May 2017 The road to European Reference Networks (ERNs) Imagine if the best specialists from across
More informationConsiderations in Choosing Screening Conditions: One (US) Approach
22 Plenary Considerations in Choosing Screening Conditions: One (US) Approach Bradford L Therrell Jr, 1,2 MS, PhD Abstract The lack of a national policy on newborn screening (NBS) in the United States
More informationFirst Issued: 6/29/2007 Revisions: 12/10/2008, 5/12/2010
U n i t e d H e a l t h C a r e G u i d e l i n e Division UnitedHealthcare Departments Community Plan Products Children s Rehabilitative Services (CRS) State :Arizona Title: CRS Metabolic Clinical Practice
More informationPurpose. Newborn Screening- UC 260. What is NBS? What isn t NBS? History. History 2
Purpose Newborn Screening- UC 260 Edward B. Goldman, J.D. Health System Attorney University of Michigan November 13, 2003 We will review newborn screening (NBS) history Look at current NBS practices Discuss
More informationCounsyl Foresight Carrier Screen. Utmost confidence in every result
Counsyl Foresight Carrier Screen Utmost confidence in every result EXTENDING THE BENEFITS OF CARRIER SCREENING Elevate quality of care with expanded carrier screening (ECS) Carrier screening is used to
More informationProposal for EXPANDED NEWBORN SCREENING
Proposal for EXPANDED NEWBORN SCREENING Tel:+971-4-4503875 Fax:+971-4-4503874 DuBiotech, P.O.Box 212671Dubai, UAE. Email: info@easternbiotech.com www.easternbiotech.com Winner of Dubai SME100 Ranked #19
More informationMetabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius
Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):
More information